Arun C. Kaura
GlaxoSmithKline
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Arun C. Kaura.
Bioorganic & Medicinal Chemistry Letters | 1995
Aileen E Allsop; Gerald Brooks; Gordon Bruton; Steven Coulton; Peter D. Edwards; Ian Keith SmithKline Beecham Pharm. Hatton; Arun C. Kaura; Sara D McLean; Neil David Pearson; Terence C. Smale; Robert Southgate
Abstract C(3)-Penem esters and amides having the (5S)-configuration at the bridgehead are inhibitors of Escherichia coli leader peptidase, the best activity being seen with a 6-(1-acetoxyethyl) derivative having the (5S, 6S, 8R)-stereochemistry. These compounds represent the first examples of potent inhibitors of bacterial signal peptidase.
Bioorganic & Medicinal Chemistry Letters | 1998
Dashyant Dhanak; Richard M. Keenan; George Burton; Arun C. Kaura; Michael G. Darcy; Dinubhai H Shah; Lance H. Ridgers; Ann L. Breen; Paddy Lavery; David G. Tew; Andrew West
A novel class of CMV protease inhibitors based on a benzothiopyran-S,S-dioxide nucleus has been discovered. Enzyme kinetic data supports a reversible mode of inhibition for a representative member of this class, 2-(3-pyridyl-N-oxide)benzothiopyran-4-one-S,S-dioxide, 1. Experiments in the presence and absence of the disulfide reducing agent DTT suggest that the inhibition by 1 is not due to oxidative inactivation of the enzyme. Also presented are results of some SAR studies of the benzothiopyranone ring system.
Synthetic Communications | 1996
Clive Leslie Branch; Drake S. Eggleston; R. Curtis Haltiwanger; Arun C. Kaura; John W. Tyler
Abstract The title compound has been prepared in three steps from 2-methylthiosemicarbazide following acylation, cyclisation and cation exchange chromatography. It was fully characterised by the usual spectroscopic means as well as by 15N nmr spectroscopy and X-ray crystallographic analysis.
Bioorganic & Medicinal Chemistry Letters | 2000
Dashyant Dhanak; George Burton; Lisa T. Christmann; Michael G. Darcy; Kyle Elrod; Arun C. Kaura; Richard M. Keenan; John O. Link; Catherine E. Peishoff; Dinubhai H Shah
A versatile synthetic route to a novel series of bis-imidazolemethanes designed to inhibit the hCMV protease has been developed and a series of potential metal binding inhibitors has been identified. In selectivity assays, the compounds were highly specific for CMV protease and showed no inhibition (IC50 > 100 microM) of other prototypical serine proteases such as trypsin, elastase, and chymotrypsin. Although the presence of free zinc ions was found to be an absolute requirement for the in vitro biological activity of this class of inhibitor, the potency of the inhibitors could not be improved beyond the micromolar level.
Organic Letters | 2012
Mark A. Bobko; Arun C. Kaura; Karen A. Evans; Dai-Shi Su
A simple, novel, and efficient route for the synthesis of 5-amino-3-aryl-1-(tert-butyl)-1H-pyrazole-4-carboxamides 1 has been devised. Preparation of pyrazole bromide 3 from potassium tricyanomethanide can be accomplished in only two steps in good yield and features a selective Sandmeyer reaction on the corresponding diaminopyrazole. This allows for a more versatile synthesis of 5-amino-3-aryl-1-(tert-butyl)-1H-pyrazole-4-carboxamides 1 than was previously possible.
Tetrahedron Letters | 1991
John H. Bateson; Arun C. Kaura; Robert Southgate
Ozonolysis of α-ethylidene azetidinones (1) and (10) did not provide the expected α-oxoazetidinones, but afforded α-amino acid-N-carboxyanhydrides (3) and (11). Ozonolysis of α-ethylidene azetidinone (1) did not provide an oxoazetidinone (6) but gave the α-amino acid-N-carboxyanhydride (3).
Journal of The Chemical Society-perkin Transactions 1 | 1992
John H. Bateson; Stephen Christopher Martin Fell; Arun C. Kaura; Robert Southgate
Ozonolysis of (E)-7-ethylidene[3-oxa-1-azabicyclo[4.2.0]octane-2-spirocyclohexan]-8-one failed to provide the α-oxoazetidinone 2, but afforded an α-amino acid-N-carboxyanhydride [3,8-dioxa-1-azabicyclo[4.3.0]nonane-2-spirocyclohexane]-7,9-dione 5. [3-Oxa-1-azabicyclo[4.2.0]octane-2-spirocyclohexane]-7,8-dione 2 was instead obtained from the trans-ketone 9 by a sequence involving Baeyer–Villiger oxidation of the azido ketone 10.
Tetrahedron Letters | 1991
Peter D. Berry; Alison C. Brown; John C. Hanson; Arun C. Kaura; Peter H. Milner; Clive J. Moores; John Kirby Quick; Richard Neville Saunders; Robert Southgate; Neil Whittall
Abstract The development of a convenient “one pot” synthesis of 7α-formamido ACA(12) from 7-ACA(2) via quinone methide methodology is described.
Bioorganic & Medicinal Chemistry Letters | 2002
Neil David Pearson; Drake S. Eggleston; R. Curtis Haltiwanger; Martin Hibbs; Alison Laver; Arun C. Kaura
The design of conformationally restricted eight-membered ring diketones as transition state mimics of the mechanism of action of cyclotheonamides on serine proteases is described. Two target compounds are prepared from mutilin, derived from the natural product pleuromutilin. Compound 3 shows significant inhibition of plasmin and urokinase in enzyme rate assays, but an analogue 4 in which the amide moiety has been omitted does not. An X-ray crystal structure of the diketone 3 confirms the conformational predictions made by molecular modelling.
Bioorganic & Medicinal Chemistry Letters | 1993
Arun C. Kaura; Michael J. Pearson
Abstract The penems ( 2 ) and ( 4 ), attached to a catechol group via an ester linkage at C-2, have been prepared and evaluated as antibacterial agents.